These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9771615)

  • 21. Drug-targeting to the kidney: renal delivery and degradation of a naproxen-lysozyme conjugate in vivo.
    Haas M; Kluppel AC; Wartna ES; Moolenaar F; Meijer DK; de Jong PE; de Zeeuw D
    Kidney Int; 1997 Dec; 52(6):1693-9. PubMed ID: 9407519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herb-drug interaction of Andrographis paniculata (Nees) extract and andrographolide on pharmacokinetic and pharmacodynamic of naproxen in rats.
    Balap A; Lohidasan S; Sinnathambi A; Mahadik K
    J Ethnopharmacol; 2017 Jan; 195():214-221. PubMed ID: 27847337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacokinetic and biological activity profile of dexamethasone targeted to sinusoidal endothelial and Kupffer cells.
    Melgert BN; Weert B; Schellekens H; Meijer DK; Poelstra K
    J Drug Target; 2003 Jan; 11(1):1-10. PubMed ID: 12852435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro regioselective stability of beta-1-O- and 2-O-acyl glucuronides of naproxen and their covalent binding to human serum albumin.
    Iwaki M; Ogiso T; Inagawa S; Kakehi K
    J Pharm Sci; 1999 Jan; 88(1):52-7. PubMed ID: 9874702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic studies of naproxen amides of some amino acid esters with promising colorectal cancer chemopreventive activity.
    Aboul-Fadl T; Al-Hamad SS; Fouad EA
    Bioorg Chem; 2018 Feb; 76():370-379. PubMed ID: 29241109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metabolic fate of the Anti-HIV active drug carrier succinylated human serum albumin after intravenous administration in rats.
    Swart PJ; Kuipers ME; Smit C; Beljaars L; Ter Wiel J; Meijer DK
    J Drug Target; 2001 Apr; 9(2):95-109. PubMed ID: 11697111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting of sugar- and charge-modified albumins to fibrotic rat livers: the accessibility of hepatic cells after chronic bile duct ligation.
    Beljaars L; Poelstra K; Molema G; Meijer DK
    J Hepatol; 1998 Oct; 29(4):579-88. PubMed ID: 9824267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel brain targeting prodrugs of naproxen based on dimethylamino group with various linkages.
    Zhang Q; Liang Z; Chen LY; Sun X; Gong T; Zhang ZR
    Arzneimittelforschung; 2012 Jun; 62(6):261-6. PubMed ID: 22407924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal targeting of a non-steroidal anti-inflammatory drug: effects on renal prostaglandin synthesis in the rat.
    Haas M; Moolenaar F; Meijer DK; de Jong PE; de Zeeuw D
    Clin Sci (Lond); 1998 Nov; 95(5):603-9. PubMed ID: 9791047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver cell uptake and degradation of soluble immunoglobulin G immune complexes in vivo and in vitro in rats.
    Johansson AG; Løvdal T; Magnusson KE; Berg T; Skogh T
    Hepatology; 1996 Jul; 24(1):169-75. PubMed ID: 8707258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacokinetics of naproxen.
    Davies NM; Anderson KE
    Clin Pharmacokinet; 1997 Apr; 32(4):268-93. PubMed ID: 9113437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose dependent pharmacokinetics of naproxen in man.
    Niazi SK; Alam SM; Ahmad SI
    Biopharm Drug Dispos; 1996 May; 17(4):355-61. PubMed ID: 8743406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic analysis and cellular distribution of the anti-HIV compound succinylated human serum albumin (Suc-HSA) in vivo and in the isolated perfused rat liver.
    Jansen RW; Olinga P; Harms G; Meijer DK
    Pharm Res; 1993 Nov; 10(11):1611-4. PubMed ID: 8290473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetically engineered mannosylated-human serum albumin as a versatile carrier for liver-selective therapeutics.
    Hirata K; Maruyama T; Watanabe H; Maeda H; Nakajou K; Iwao Y; Ishima Y; Katsumi H; Hashida M; Otagiri M
    J Control Release; 2010 Jul; 145(1):9-16. PubMed ID: 20304018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of naproxen enantiomers to human serum albumin studied by fluorescence and room-temperature phosphorescence.
    Lammers I; Lhiaubet-Vallet V; Ariese F; Miranda MA; Gooijer C
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Mar; 105():67-73. PubMed ID: 23295212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative pharmacokinetic, immunologic and hematologic studies on the anti-HIV-1/2 compounds aconitylated and succinylated HSA.
    Swart PJ; Beljaars E; Smit C; Pasma A; Schuitemaker H; Meijer DK
    J Drug Target; 1996; 4(2):109-16. PubMed ID: 8894971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Disease-Related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats.
    Li X; DuBois DC; Almon RR; Jusko WJ
    Drug Metab Dispos; 2017 May; 45(5):476-483. PubMed ID: 28246126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the amino acids of human serum albumin involved in the reaction with the naproxen acyl coenzyme A thioester using liquid chromatography combined with fluorescence and mass spectrometric detection.
    Olsen J; Bjørnsdottir I; Tjørnelund J; Honoré Hansen S
    Anal Biochem; 2003 Jan; 312(2):148-56. PubMed ID: 12531199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation, in vitro characterization and in vivo release of naproxen loaded in poly-caprolactone nanoparticles.
    Rodrigues MR; Lanzarini CM; Ricci-Junior E
    Pharm Dev Technol; 2011 Feb; 16(1):12-21. PubMed ID: 20001271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells.
    Beljaars L; Molema G; Weert B; Bonnema H; Olinga P; Groothuis GM; Meijer DK; Poelstra K
    Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.